XML 31 R31.htm IDEA: XBRL DOCUMENT
v2.4.1.9

DERIVATIVE FINANCIAL INSTRUMENTS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2015
DERIVATIVE FINANCIAL INSTRUMENTS |
Schedule of fair value of the Company's derivative financial instruments as well as their classification on the condensed consolidated balance sheets | The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of March 31, 2015 (in thousands):
|  |  |  | Fair Value |
Derivative Instrument |  | Balance Sheet Location |  | March 31, 2015 |  | December 31, 2014 |
Interest Rate Swaps |  | Accrued liabilities |  | $ | (102 | ) | $ | (2 | )
|  | Total Liabilities |  | $ | (102 | ) | $ | (2 | )
Schedule of effect of the Company's derivative financial instruments on the condensed consolidated statement of income and comprehensive income | The effect of the Company’s derivative financial instruments on the condensed consolidated statements of income and comprehensive income is as follows (in thousands):
|  | Net deferral in OCI of |  |  |  | Net reclassification from AOCI |
|  | derivatives (effective portion) |  | Statement of |  | into income (effective portion) |
Derivative |  | For the quarter ended March 31, |  | earnings |  | For the quarter ended March 31, |
Instruments |  | 2015 |  | 2014 |  | classification |  | 2015 |  | 2014 |
Interest Rate Swaps |  | $ | (151 | ) | $ | (68 | ) | Interest expense |  | $ | (51 | ) | $ | (58 | )
|  | Amount recognized in income |
|  | (ineffective portion and amount |
|  | excluded from effectiveness |
Statement of |  | testing) |
earnings |  | For the quarter ended March 31, |
classification |  | 2015 |  | 2014 |
Other (expense) |  | $ | — |  | $ | — |

X
- Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration